{"version":"1.0","type":"link","title":"A phase-I study of second-line S-IROX for unresectable pancreatic cancer after gemcitabine plus nab-paclitaxel failure.","author_name":"Okuno M 외","author_url":"https://prs-insight.online/author/Okuno%20M","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/157231","thumbnail_width":1200,"thumbnail_height":630}